Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Archer

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Contraception|February 9, 2002
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy studyC Mauck, D H Weiner, S Ballagh, et al.
Climacteric : the Journal of the International Menopause Society|October 31, 2015
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partnerF Labrie, M Montesino, D F Archer, et al.
Human Reproduction (Oxford, England)|October 21, 2000
The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometriumD S Charnock-Jones, A M Macpherson, D F Archer, et al.
Climacteric : the Journal of the International Menopause Society|March 28, 2008
Updated practical recommendations for hormone replacement therapy in the peri- and postmenopauseM H Birkhäuser, N Panay, D F Archer, et al.
Contraception|September 27, 2015
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiolD F Archer, M A Thomas, J Conard, et al.
Climacteric : the Journal of the International Menopause Society|August 15, 2017
Menopausal hormone therapy for primary prevention: why the USPSTF is wrongR D Langer, J A Simon, A Pines, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study GroupW H Utian, K A Burry, D F Archer, et al.
Contraception|November 5, 1999
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopyC K Mauck, M M Callahan, J Baker, et al.
Contraception|June 1, 1996
Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicideC Mauck, L H Glover, E Miller, et al.
Climacteric : the Journal of the International Menopause Society|May 16, 2013
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife healthT J de Villiers, A Pines, N Panay, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Contraception|February 9, 2002
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy studyC Mauck, D H Weiner, S Ballagh, et al.
Climacteric : the Journal of the International Menopause Society|October 31, 2015
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partnerF Labrie, M Montesino, D F Archer, et al.
Human Reproduction (Oxford, England)|October 21, 2000
The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometriumD S Charnock-Jones, A M Macpherson, D F Archer, et al.
Climacteric : the Journal of the International Menopause Society|March 28, 2008
Updated practical recommendations for hormone replacement therapy in the peri- and postmenopauseM H Birkhäuser, N Panay, D F Archer, et al.
Contraception|September 27, 2015
Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiolD F Archer, M A Thomas, J Conard, et al.
Climacteric : the Journal of the International Menopause Society|August 15, 2017
Menopausal hormone therapy for primary prevention: why the USPSTF is wrongR D Langer, J A Simon, A Pines, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study GroupW H Utian, K A Burry, D F Archer, et al.
Contraception|November 5, 1999
The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopyC K Mauck, M M Callahan, J Baker, et al.
Contraception|June 1, 1996
Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicideC Mauck, L H Glover, E Miller, et al.
Climacteric : the Journal of the International Menopause Society|May 16, 2013
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife healthT J de Villiers, A Pines, N Panay, et al.
Pageof 12